Actinium Pharmaceuticals To Present New Clinical Findings From SIERRA Trial Supporting The Iomab-ACT Program For Targeted Lymphodepletion For CAR-T And Adoptive Cell Therapies At ASH 2019 Dec. 7-10
luke@benzinga.com